135 related articles for article (PubMed ID: 33948984)
21. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
22. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
23. Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer.
Shan X; Wang D; Chen J; Xiao X; Jiang Y; Wang Y; Fan Y
J Comput Assist Tomogr; 2013; 37(1):22-8. PubMed ID: 23321829
[TBL] [Abstract][Full Text] [Related]
24. Correlation of vascular endothelial growth factor and hypoxia-inducible factor-1α expression with pathological renal artery changes in patients with renal cell carcinoma.
Demirović A; Tomas D; Tomić K; Spajić B; Ibukić A; Cupić H; Krušlin B
Scand J Urol; 2014 Feb; 48(1):34-40. PubMed ID: 24256617
[TBL] [Abstract][Full Text] [Related]
25. [Expressions of hypoxia inducible factor-1alpha and vascular endothelial growth factor in human renal cell carcinoma].
Shao ZQ; Zheng SB; Xiao YJ; Tan WL; Chen T; Qi H; Jiang YD; Yu ZC; Zhang HJ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1034-6. PubMed ID: 16109571
[TBL] [Abstract][Full Text] [Related]
26. CD133 expression in renal cell carcinoma (RCC) is correlated with nuclear hypoxia-inducing factor 1α (HIF-1α).
Sun C; Song H; Zhang H; Hou C; Zhai T; Huang L; Zhang L
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1619-24. PubMed ID: 22614155
[TBL] [Abstract][Full Text] [Related]
27. [Expression of hypoxia inducible factor-1α and correlated target genes in human laryngeal carcinoma].
XU O; LI XM; WANG MX; QU YT; LU XY; SHAN CG; SUN QJ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):330-3. PubMed ID: 22800355
[TBL] [Abstract][Full Text] [Related]
28. Survival in patients with clear cell renal cell carcinoma is predicted by HIF-1α expression.
Minardi D; Lucarini G; Santoni M; Mazzucchelli R; Burattini L; Conti A; Principi E; Bianconi M; Scartozzi M; Milanese G; Di Primio R; Montironi R; Cascinu S; Muzzonigro G
Anticancer Res; 2015 Jan; 35(1):433-8. PubMed ID: 25550584
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.
Tickoo SK; Alden D; Olgac S; Fine SW; Russo P; Kondagunta GV; Motzer RJ; Reuter VE
J Urol; 2007 Apr; 177(4):1258-63. PubMed ID: 17382701
[TBL] [Abstract][Full Text] [Related]
30. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
31. [Expression of hypoxia-inducible factor-1-alpha, hypoxia-inducible factor-2alpha and vascular endothelial growth factor in sporadic clear cell renal cell renal cell carcinoma and their significance in the pathogenesis thereof].
Zhang N; Gong K; Yang XY; Xin DQ; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(22):1526-9. PubMed ID: 16854277
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
33. hERG1 and CA IX expression are associated with disease recurrence in surgically resected clear cell renal carcinoma.
Lastraioli E; Pillozzi S; Mari A; Tellini R; Duranti C; Baldazzi V; Venturini S; Minervini A; Lapini A; Nesi G; Carini M; Arcangeli A
Eur J Surg Oncol; 2020 Jan; 46(1):209-215. PubMed ID: 31679954
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression.
Tatli Dogan H; Kiran M; Bilgin B; Kiliçarslan A; Sendur MAN; Yalçin B; Ardiçoglu A; Atmaca AF; Gumuskaya B
Diagn Pathol; 2018 Aug; 13(1):60. PubMed ID: 30144808
[TBL] [Abstract][Full Text] [Related]
35. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
Ambrosio MR; Di Serio C; Danza G; Rocca BJ; Ginori A; Prudovsky I; Marchionni N; Del Vecchio MT; Tarantini F
Diagn Pathol; 2016 May; 11(1):45. PubMed ID: 27225200
[TBL] [Abstract][Full Text] [Related]
36. Expression of endogenous hypoxia markers in vulvar squamous cell carcinoma.
Li YZ; Li SL; Li X; Wang LJ; Wang JL; Xu JW; Wu ZH; Gong L; Zhang XD
Asian Pac J Cancer Prev; 2012; 13(8):3675-80. PubMed ID: 23098453
[TBL] [Abstract][Full Text] [Related]
37. Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer.
Kim SJ; Rabbani ZN; Dewhirst MW; Vujaskovic Z; Vollmer RT; Schreiber EG; Oosterwijk E; Kelley MJ
Lung Cancer; 2005 Sep; 49(3):325-35. PubMed ID: 15935515
[TBL] [Abstract][Full Text] [Related]
38. [Expression of BNIP3 and its correlations to HIF-1alpha and VEGF in clear cell renal cell carcinoma].
Luo L; Xiong ZB; Zeng H; Chen N; Chen XQ; Zhang P; Li X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):79-82. PubMed ID: 22455137
[TBL] [Abstract][Full Text] [Related]
39. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
40. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE
Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]